The EPHA2/ephrinA3axis acts as a responder to low oxygen levels, utilizes SREBP1-mediated ACLY transcription to promote metabolic reprogramming, and induces higher self-renewal and tumor-initiating capacity in HCC cells (EpCam, CD13, and CD24) [83]. Here, EPHA2 is linked to hepatocellular carcinoma.